NO922846L - Ditianer - Google Patents

Ditianer

Info

Publication number
NO922846L
NO922846L NO92922846A NO922846A NO922846L NO 922846 L NO922846 L NO 922846L NO 92922846 A NO92922846 A NO 92922846A NO 922846 A NO922846 A NO 922846A NO 922846 L NO922846 L NO 922846L
Authority
NO
Norway
Prior art keywords
elimination
compounds
reduction
formula
treatment
Prior art date
Application number
NO92922846A
Other languages
English (en)
Norwegian (no)
Other versions
NO922846D0 (no
Inventor
James F Eliason
Henri Ramuz
Franz Alois Kaufmann-Schmid
Original Assignee
Hoffmann La Roche
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Hoffmann La Roche filed Critical Hoffmann La Roche
Publication of NO922846D0 publication Critical patent/NO922846D0/no
Publication of NO922846L publication Critical patent/NO922846L/no

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D409/00Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms
    • C07D409/02Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms containing two hetero rings
    • C07D409/04Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms containing two hetero rings directly linked by a ring-member-to-ring-member bond
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P33/00Antiparasitic agents
    • A61P33/02Antiprotozoals, e.g. for leishmaniasis, trichomoniasis, toxoplasmosis
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00Antineoplastic agents
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D339/00Heterocyclic compounds containing rings having two sulfur atoms as the only ring hetero atoms
    • C07D339/08Six-membered rings
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D409/00Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms
    • C07D409/02Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms containing two hetero rings
    • C07D409/12Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms containing two hetero rings linked by a chain containing hetero atoms as chain links
    • YGENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y02TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
    • Y02ATECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE
    • Y02A50/00TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE in human health protection, e.g. against extreme weather
    • Y02A50/30Against vector-borne diseases, e.g. mosquito-borne, fly-borne, tick-borne or waterborne diseases whose impact is exacerbated by climate change

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • General Chemical & Material Sciences (AREA)
  • Public Health (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Heterocyclic Compounds Containing Sulfur Atoms (AREA)
  • Plural Heterocyclic Compounds (AREA)
NO92922846A 1991-07-18 1992-07-17 Ditianer NO922846L (no)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
CH214491 1991-07-18

Publications (2)

Publication Number Publication Date
NO922846D0 NO922846D0 (no) 1992-07-17
NO922846L true NO922846L (no) 1993-01-19

Family

ID=4226902

Family Applications (1)

Application Number Title Priority Date Filing Date
NO92922846A NO922846L (no) 1991-07-18 1992-07-17 Ditianer

Country Status (19)

Country Link
US (2) US5302727A (cs)
EP (1) EP0523493A1 (cs)
JP (1) JPH05208972A (cs)
KR (1) KR930002341A (cs)
CN (1) CN1031754C (cs)
AU (1) AU657142B2 (cs)
BR (1) BR9202719A (cs)
CA (1) CA2074062A1 (cs)
CZ (1) CZ281619B6 (cs)
FI (1) FI923292L (cs)
HU (1) HUT62285A (cs)
IE (1) IE922338A1 (cs)
IL (1) IL102477A (cs)
MX (1) MX9204138A (cs)
NO (1) NO922846L (cs)
NZ (1) NZ243545A (cs)
TW (1) TW223071B (cs)
UY (1) UY23447A1 (cs)
ZA (1) ZA925185B (cs)

Families Citing this family (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6235785B1 (en) 1994-08-31 2001-05-22 Eli Lilly And Company Methods for identifying and treating resistant tumors
GB9524681D0 (en) 1995-12-02 1996-01-31 Knoll Ag Chemical process
US6664287B2 (en) * 2000-03-15 2003-12-16 Bethesda Pharmaceuticals, Inc. Antioxidants
US6693099B2 (en) 2000-10-17 2004-02-17 The Procter & Gamble Company Substituted piperazine compounds optionally containing a quinolyl moiety for treating multidrug resistance
US6376514B1 (en) 2000-10-17 2002-04-23 The Procter & Gamble Co. Substituted six-membered heterocyclic compounds useful for treating multidrug resistance and compositions and methods thereof
CA2858837C (en) * 2011-12-30 2022-08-30 Reviva Pharmaceuticals, Inc. Compositions, synthesis, and methods of using phenylcycloalkylmethylamine derivatives
CN105085471B (zh) * 2014-05-16 2019-06-11 兰州大学 一种2-取代-1,3-二噻烷衍生物的制备方法
CN104710404B (zh) * 2015-03-31 2016-03-23 西安科技大学 一种取代-1,3-二噻烷类化合物的制备方法

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4003914A (en) * 1973-12-21 1977-01-18 Hoffmann-La Roche Inc. Sulphur containing derivatives
US4127588A (en) * 1976-10-01 1978-11-28 Hoffmann-La Roche Inc. Sulphur containing derivatives

Also Published As

Publication number Publication date
MX9204138A (es) 1993-07-01
NZ243545A (en) 1994-11-25
US5302727A (en) 1994-04-12
ZA925185B (en) 1993-04-29
CA2074062A1 (en) 1993-01-19
CN1031754C (zh) 1996-05-08
TW223071B (cs) 1994-05-01
NO922846D0 (no) 1992-07-17
IL102477A0 (en) 1993-01-14
BR9202719A (pt) 1993-03-23
UY23447A1 (es) 1993-01-07
CN1068569A (zh) 1993-02-03
HU9202320D0 (en) 1992-10-28
FI923292A7 (fi) 1993-01-19
FI923292L (fi) 1993-01-19
JPH05208972A (ja) 1993-08-20
IL102477A (en) 1996-09-12
EP0523493A1 (de) 1993-01-20
HUT62285A (en) 1993-04-28
AU2034992A (en) 1993-01-21
CZ218992A3 (en) 1993-02-17
AU657142B2 (en) 1995-03-02
KR930002341A (ko) 1993-02-23
IE922338A1 (en) 1993-01-27
FI923292A0 (fi) 1992-07-17
CZ281619B6 (cs) 1996-11-13
US5405866A (en) 1995-04-11

Similar Documents

Publication Publication Date Title
IE781619L (en) Phosphonoacyl proline compounds.
CA2124680A1 (en) Piperazine derivatives as 5-ht1a antagonists
DE69013607D1 (de) Pyrazol-Derivate, Verfahren zu deren Herstellung und Anwendung.
HUT44044A (en) Process for preparing place-specific alkylating agents
NO177643C (no) Katodisk elektrolytisk utfellbar, selv-tverrbindbar polymer
EP0389995A3 (en) Isoquinoline derivatives for the treatment of glaucoma or ocular hypertension
CA2091172A1 (en) Antiviral compounds and antihypertensive compounds
DK0756595T3 (da) Substituerede 1,3-oxathiolaner med antivirale egenskaber
DK0437030T3 (da) Anvendelse af 4-substituerede imidazoler til nedsættelse af det intraoculære tryk
DK106586A (da) Cyklopenta(d)pyrimidinderivater samt deres fremstilling og anvendelse
NO922846L (no) Ditianer
GR3004250T3 (cs)
DK0482071T3 (da) Nye antivirale midler
LV10422A (lv) Jaunie fluor-naftacendioni to glikozetie atvasinajumi un vinu razosanas panemiens
FI851611L (fi) Heterocykliska aminokomponenter.
ES2053868T3 (es) 3-aminosidnoniminas substituidas, procedimientos para su obtencion y su empleo.
MA20829A1 (fr) Nouvelles anthracyclines et compositions les contenant
AU569152B2 (en) Enkephalinase inhibitors
DK270282A (da) 6,7-diethoxy-1-(4-ethoxy-3-hydroxy-benzyl)-3,4-dihydro-isoquinolin og salte deraf deres fremstilling og anvendelse
HUT54688A (en) Process for producing compounds utilizable for treating ulcus and pharmaceutical compositions containing them as active components
AU557772B2 (en) I-furyl-3,4-dihydroisoquinolines
PT84204A (en) Process for the manufacture of substituted pyrrolidinones
IT1244649B (it) Procedimento per il trattamento di substrati com composti aromatici contenenti gruppi solfo, composizioni contenenti tali composti e loro preparazione